The bioavailability of oral intermediate-dose methotrexate: Effect of dose subdivision, formulation, and timing in the chemotherapy cycle
Year: 1984
Type: article
DOI: 10.1007/bf00257121
Institution: St Bartholomew's Hospital
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2885961944
